Thyroid disease

Controlled Antenatal Thyroid Screening Study III: Effects of Gestational Thyroid Status on Adolescent Brain Morphology

J Clin Endocrinol MetabPublished Follow-up neuroimaging study of the Controlled Antenatal Thyroid Screening (CATS) randomised trial

Authors' conclusion

We found no evidence that SGTF was associated with differences in adolescent brain morphology, and no effect of levothyroxine supplementation.

Study context

Population
Children aged 11 to 16 years born to mothers in the CATS study (mothers with suboptimal gestational thyroid function (SGTF) randomly assigned to LT4 or no supplementation from ≈12 weeks' gestation), with usable T1-weighted magnetic resonance imaging (MRI) data85 with usable MRI
Participants
21 / 24 / 21 / 20
Comparison
Untreated SGTF vs normal GTF vs treated SGTF
  • Untreated SGTFn = 21
  • Normal GTFn = 24reference
  • Optimally treatedn = 21
  • Overtreatedn = 20
Primary endpoint
Association of SGTF and its treatment with global brain volumes
Methodological detailsT1-weighted structural MRI, adjusted for age, sex and pubertal scores
  • T1-weighted structural MRI
  • Adjusted for age, sex and pubertal scores

Primary result

As reported in the abstract

Global brain volumetric measures
  • No significant differences in global brain volumetric measures between groups
  • Between Untreated SGTF and Normal GTF: P = 0.373
  • Adjusted for age, sex and pubertal scores

Further findings

Maternal TSH and free thyroxine (FT4) levels vs global and subregional brain volumes

Weak positive correlations between maternal TSH, but not FT4, levels and several brain volumes; did not survive testing for multiple comparisons

Original publication

Controlled Antenatal Thyroid Screening Study III: Effects of Gestational Thyroid Status on Adolescent Brain Morphology. J Clin Endocrinol Metab. Published 15 May 2024. doi:10.1210/clinem/dgae338

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.